These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22579649)

  • 1. Synergistic growth inhibition of human hepatocellular carcinoma cells by acyclic retinoid and GW4064, a farnesoid X receptor ligand.
    Ohno T; Shirakami Y; Shimizu M; Kubota M; Sakai H; Yasuda Y; Kochi T; Tsurumi H; Moriwaki H
    Cancer Lett; 2012 Oct; 323(2):215-22. PubMed ID: 22579649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyclic retinoid synergises with valproic acid to inhibit growth in human hepatocellular carcinoma cells.
    Tatebe H; Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Tsurumi H; Moriwaki H
    Cancer Lett; 2009 Nov; 285(2):210-7. PubMed ID: 19520494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic growth inhibition by 9-cis-retinoic acid plus trastuzumab in human hepatocellular carcinoma cells.
    Tatebe H; Shimizu M; Shirakami Y; Tsurumi H; Moriwaki H
    Clin Cancer Res; 2008 May; 14(9):2806-12. PubMed ID: 18451248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
    Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
    Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells.
    Baba A; Shimizu M; Ohno T; Shirakami Y; Kubota M; Kochi T; Terakura D; Tsurumi H; Moriwaki H
    BMC Cancer; 2013 Oct; 13():465. PubMed ID: 24103747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid.
    Matsushima-Nishiwaki R; Okuno M; Takano Y; Kojima S; Friedman SL; Moriwaki H
    Carcinogenesis; 2003 Aug; 24(8):1353-9. PubMed ID: 12807734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic growth inhibition by acyclic retinoid and vitamin K2 in human hepatocellular carcinoma cells.
    Kanamori T; Shimizu M; Okuno M; Matsushima-Nishiwaki R; Tsurumi H; Kojima S; Moriwaki H
    Cancer Sci; 2007 Mar; 98(3):431-7. PubMed ID: 17270033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice.
    Shimizu M; Sakai H; Shirakami Y; Iwasa J; Yasuda Y; Kubota M; Takai K; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Prev Res (Phila); 2011 Jan; 4(1):128-36. PubMed ID: 21071580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (review).
    Kojima S; Okuno M; Matsushima-Nishiwaki R; Friedman SL; Moriwaki H
    Int J Oncol; 2004 Apr; 24(4):797-805. PubMed ID: 15010815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells.
    Shimizu M; Suzui M; Deguchi A; Lim JT; Xiao D; Hayes JH; Papadopoulos KP; Weinstein IB
    Clin Cancer Res; 2004 Oct; 10(19):6710-21. PubMed ID: 15475462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FXR induces SOCS3 and suppresses hepatocellular carcinoma.
    Guo F; Xu Z; Zhang Y; Jiang P; Huang G; Chen S; Lyu X; Zheng P; Zhao X; Zeng Y; Wang S; He F
    Oncotarget; 2015 Oct; 6(33):34606-16. PubMed ID: 26416445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic induction of apoptosis by acyclic retinoid and interferon-beta in human hepatocellular carcinoma cells.
    Obora A; Shiratori Y; Okuno M; Adachi S; Takano Y; Matsushima-Nishiwaki R; Yasuda I; Yamada Y; Akita K; Sano T; Shimada J; Kojima S; Okano Y; Friedman SL; Moriwaki H
    Hepatology; 2002 Nov; 36(5):1115-24. PubMed ID: 12395321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
    Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyclic retinoid, a novel synthetic retinoid, induces growth inhibition, apoptosis, and changes in mRNA expression of cell cycle- and differentiation-related molecules in human colon carcinoma cells.
    Suzui M; Sunagawa N; Chiba I; Moriwaki H; Yoshimi N
    Int J Oncol; 2006 May; 28(5):1193-9. PubMed ID: 16596235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma.
    Matsushima-Nishiwaki R; Okuno M; Adachi S; Sano T; Akita K; Moriwaki H; Friedman SL; Kojima S
    Cancer Res; 2001 Oct; 61(20):7675-82. PubMed ID: 11606411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.
    Shimizu M; Shirakami Y; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Moriwaki H
    Mol Nutr Food Res; 2014 Jan; 58(1):124-35. PubMed ID: 24273224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells.
    Ninomiya S; Shimizu M; Imai K; Takai K; Shiraki M; Hara T; Tsurumi H; Ishizaki S; Moriwaki H
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2092-100. PubMed ID: 21952585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
    Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
    Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of acyclic retinoid in the chemoprevention of hepatocellular carcinoma: basic aspects, clinical applications, and future prospects.
    Shimizu M; Imai K; Takai K; Moriwaki H
    Curr Cancer Drug Targets; 2012 Nov; 12(9):1119-28. PubMed ID: 22873214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.
    Vu-Dac N; Gervois P; Torra IP; Fruchart JC; Kosykh V; Kooistra T; Princen HM; Dallongeville J; Staels B
    J Clin Invest; 1998 Aug; 102(3):625-32. PubMed ID: 9691099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.